Literature DB >> 1951305

Hyperammonemia following allogeneic bone marrow transplantation.

N Tse1, S Cederbaum, J A Glaspy.   

Abstract

Hyperammonemia is a rare and serious complication of intensive cytotoxic chemotherapy. We report the case of a patient who developed profound idiopathic hyperammonemia following bone marrow transplantation for chronic myelogenous leukemia. Despite rapid institution of hemodialysis, sodium benzoate, and the experimental agent sodium phenylacetate, the patient ultimately succumbed to complications of this metabolic derangement. The literature is reviewed, and recommendations for an approach to this complication of marrow transplantation are proposed.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1951305     DOI： 10.1002/ajh.2830380213

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  10 in total

1.  Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.

Authors:  V Praphanphoj; S A Boyadjiev; L J Waber; S W Brusilow; M T Geraghty
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

2.  Hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplant.

Authors:  Chase A Cannon; Maria A Corcorran; Kathryn W Shaw; Martin Montenovo; Lena Sibulesky; Jorge D Reyes; Stephen C Rayhill; Anne M Larson; Patricia A Kritek; Shewit Giovanni; Iris de Castro; Nayan Arora; Robert M Rakita
Journal:  Transpl Infect Dis       Date:  2020-04-30       Impact factor: 2.228

3.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 4.  Hyperammonemia After Lung Transplantation: Systematic Review and a Mini Case Series.

Authors:  Amir Y Kamel; Amir M Emtiazjoo; Lauren Adkins; Abbas Shahmohammadi; Hassan Alnuaimat; Andres Pelaez; Tiago Machuca; Mauricio Pipkin; Hyun-Wook Lee; I David Weiner; Satish Chandrashekaran
Journal:  Transpl Int       Date:  2022-05-03       Impact factor: 3.842

5.  Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation.

Authors:  Hiroi Eguchi; Toshihiko Kakiuchi; Masanori Nishi; Kanako Kojima-Ishii; Kei Nishiyama; Yuhki Koga; Muneaki Matsuo
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.569

6.  Sudden severe hyperammonemia and status epilepticus -a case report-.

Authors:  Woo-Kyung Shin; Young-Eun Jang; Hannah Lee; Se-Hee Min; Ho-Geol Ryu
Journal:  Korean J Anesthesiol       Date:  2013-09-25

7.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

8.  Unexplained Fatal Hyperammonemia in a Patient With New Diagnosis of Acute Monoblastic Leukemia.

Authors:  Mohamed Fayed; Nimesh Patel; Yahia Al Turk; Patrick B Bradley
Journal:  Cureus       Date:  2021-12-02

9.  Contribution of Uremia to Ureaplasma-Induced Hyperammonemia.

Authors:  Derek Fleming; Scott A Cunningham; Robin Patel
Journal:  Microbiol Spectr       Date:  2022-02-16

10.  A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum.

Authors:  Derek Fleming; Melissa Karau; Robin Patel
Journal:  J Microbiol Methods       Date:  2020-12-30       Impact factor: 2.363
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.